# Mutual Capital Partners

> Mutual Capital Partners is a VC fund backing Health Care and Medical Device. See 45 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Westlake, United States
- Total investments: 45
- Last investment: Jul 2026
- Lead investor: 38%
- Fund size: $35M
- Last fund: Aug 2023
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/mutual-capital-partners
- X (Twitter): https://twitter.com/MCPcleveland?lang=en
- Website: https://www.mutualcapitalpartners.com/

Mutual Capital Partners is a VC fund in Westlake focused on Health Care and Medical Device. Due to the lack of venture capital outside the major tech hubs, we created Mutual Capital Partners in 2004 to lead or co-lead investments in promising companies looking for venture capital. Our focus is on medical device and healthcare IT companies. Management is a key focus for us and we work with the 100+ investors in our funds to assist us indue diligence, make customer introductions for our portfolio companies, and provide ongoing advice and counsel to our portfolio executives.

## Contacts

5 contacts available for Mutual Capital Partners. Shizune tracks 4 team members at Mutual Capital Partners. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/mutual-capital-partners-funds?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 14 | 31% |
| Medical Device | 10 | 22% |
| Medical | 6 | 13% |
| Information Technology | 4 | 9% |
| Software | 3 | 7% |

48 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 13 | 29% |
| Series B | 8 | 18% |
| Series D | 6 | 13% |
| Series C | 5 | 11% |
| Funding Round | 5 | 11% |

7 stages tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Rick Sapio | Co-founder, GP Advisory Board Member | 0 | https://shizune.co/investors/profile/rick-sapio-2 |
| Wayne Wallace | Co-Founder | 11 | https://shizune.co/investors/profile/wayne-wallace |
| Bill Trainor | Co-founder, General Partner, and Managing Director | 14 | https://shizune.co/investors/profile/bill-trainor |
| Liz Todia | Principal | 2 | https://shizune.co/investors/profile/liz-todia |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| TYBR Health | TYBR is a medical device company developing a sprayable hydrogel to keep internal organs scar-free after surgery. Internal scarring is the #1 complication of surgery, and TYBR's naturally derived solution reduces scarring by 75% preclinically. It was founded by Tim Keane and Alex Smith in Houston, Texas in 2020, | $30M | Series A | Jul 21, 2026 |  |
| Cooler Heads | Cooler Heads develops cold caps designed for chemotherapy patients. | $11M | Series A | Jul 22, 2025 |  |
| Olio | Olio is an information technology company that offers a mobile-based software application platform that transforms post-acute engagement during this crisis and beyond. Olio gives health systems real-time visibility into patient location and status. The company was founded in 2017 by Ben Forrest and headquartered in Carmel, Indiana. | $11M | Series B | May 12, 2025 |  |
| Catalyst OrthoScience | Catalyst OrthoScience is an early stage medical device company that is bringing the Catalyst CSR total shoulder to market. The CSR total shoulder is an innovative, streamlined solution that is associated with less stretching of the muscles and ligaments in order to place the implants. It is designed to be a more natural solution with a focus onrapid recovery for the patient. | $20M | Venture - Series Unknown | Sep 10, 2024 |  |
| Redi.Health | Redi.Health is a healthcare technology company that develops health management platforms for patients. The company aims to connect patients with chronic diseases to patient support programs. These programs are created in partnership with pharmaceutical manufacturers and are always free to patients.Founded in 2021, the company is based inColumbus, Ohio, United States. | $14M | Series B | Feb 28, 2024 |  |
| SPR Therapeutics | SPRA Therapeutics is a medical device company that is commercializing pain treatments utilizing its proprietary peripheral nerve stimulation (PNS) products. They are developing a pipeline of neurostimulation pain therapies that will exploit the same physiologic mechanism of action, proprietary technology, and clinical approach. The first product tobe commercialized is the SMARTPATCHâ„¢ PNS System, which is a short-term, minimally invasive system that is simple to deliver and can be used for up to 30 days to stimulate electrically a peripheral nerve to relieve pain. | $25M | Series D | Feb 01, 2024 |  |
| iotaMotion | IotaMotion standardizes cochlear implant insertion expanding access to cochlear interventions for surgeons and patients. Its open-platform robotic-assisted system aims to decrease surgical variability by controlling the speed and acceleration of electrode insertion. | $12M | Series A | Jul 26, 2023 |  |
| Authenticx | Authenticx is a developer of a platform that helps healthcare organizations analyze and activate customer interaction data at scale. Its platform leverages its clients' existing customer interaction data to dive deeper into who their customers are, what they care about, and how effectively their needs are being met, enabling healthcareorganizations to create better revenue strategies and improve profitability.Authenticx was founded in 2018 and is headquartered in Carmel, Indiana. | $20M | Series B | Jan 17, 2023 |  |
| Elevation Spine | Elevation Spine is a medical device company headquartered in Monterey, CA. They are focused on innovating spinal implants with proven technology and materials using proprietary product designs. | $11M | Series B | Sep 19, 2022 |  |
| Redi.Health | Redi.Health is a healthcare technology company that develops health management platforms for patients. The company aims to connect patients with chronic diseases to patient support programs. These programs are created in partnership with pharmaceutical manufacturers and are always free to patients.Founded in 2021, the company is based inColumbus, Ohio, United States. |  |  | Aug 31, 2022 |  |

10 of 45 investments shown.

## Co-investors
- [RC Capital](https://shizune.co/investors/profile/river-cities-capital) — VC Fund, 12 deals together
- [Allos Ventures](https://shizune.co/investors/profile/allos-ventures) — VC Fund, 11 deals together
- [JumpStart Inc.](https://shizune.co/investors/profile/jumpstartinc) — VC Fund, 7 deals together
- [CoreNetwork Fund](https://shizune.co/investors/profile/corenetwork-fund) — VC Fund, 6 deals together
- [Technology Venture Partners US](https://shizune.co/investors/profile/technology-venture-partners-us) — VC Fund, 6 deals together
- [M25](https://shizune.co/investors/profile/M25-VC) — VC Fund, 5 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Mutual Capital Partners invest in?

Mutual Capital Partners invests primarily in Health Care, Medical Device and Medical startups, most often at Series A and Series B stage. Most of the 45 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Mutual Capital Partners?

Public channels for Mutual Capital Partners include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Mutual Capital Partners?

The team at Mutual Capital Partners includes Rick Sapio (Co-founder, GP Advisory Board Member), Wayne Wallace (Co-Founder) and Bill Trainor (Co-founder, General Partner, and Managing Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co